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Abstract.  The development of hydrogels for protein delivery requires protein-hydrogel 
interactions that cause minimal disruption of the protein’s biological activity.  Biological 
activity can be influenced by factors such as orientation and conformation.  Hydrogels 
must promote the adsorption of biomolecules onto the surface and the diffusion of 
biomolecules into the porous network at the surface, while maintaining native protein 
conformation, keeping the protein in an accessible orientation for receptor binding, and 
maximizing protein release.  We report here the evaluation of (hydroxyethyl) 
methacrylate (HEMA)-based hydrogel systems for the delivery of keratinocyte growth 
factor (KGF) to promote re-epithelialization in wound healing.  In this work, we 
characterize two hydrogel blends in addition to HEMA alone, and report how protein 
orientation, conformation, and protein release is affected.  The first blend incorporates 
methyl methacrylate (MMA), which is known to promote adsorption of protein to its 
surface due to its hydrophobicity. The second blend incorporates methacrylic acid 
(MAA), which is known to promote the diffusion of protein into its surface due to its 
hydrophilicity.  We find that the KGF at the surface of the HEMA/MMA blend appears 
to be more orientationally accessible and conformationally active than KGF at the surface 
of the HEMA/MAA blend.  We also report that KGF at the surface of the HEMA/MAA 
blend becomes conformationally denatured, likely due to hydrogen bonding. While KGF 
at the surface of these blends can be differentiated by FTIR-ATR spectroscopy and ToF-
SIMS in conjunction with PCA, KGF swelling, uptake, and release profiles are 
indistinguishable. The differences in KGF orientation and conformation between these 
blends may result in different biological responses in future cell-based experiments.   
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I. INTRODUCTION 
The development of hydrogels as clinically translatable protein delivery devices 
involves engineering a delicate balance of efficient, localized and controlled protein 
release, while retaining the native conformation and orientation of protein in order for it 
to perform its biological function.  (Hydroxyethyl)methacrylate (HEMA) hydrogels have 
been of interest for several decades as drug delivery vehicles since adsorption and 
diffusion of biomolecules into their porous network structure was observed in contact 
lens research1.  HEMA hydrogels are swelling materials that are able to take up a large 
amount of water which gives them properties similar to those of biological tissues2.  
While the development of HEMA or alternative hydrogel-based small molecule delivery 
has been extensively studied given the ease of diffusion into the hydrogel porous 
network, protein delivery poses more complex issues3.  The hydrogel must possess 
characteristics that efficiently promote adsorption and diffusion of protein onto the 
surface and into the porous network, (1) while maintaining the native conformation of the 
protein, (2) presenting the protein in an orientation allowing for binding to its target cell 
surface receptors, and (3) allowing for maximized protein release.  
 We are specifically interested in the development of a bioadhesive protein 
delivery device to treat traumatic or chronic wounds of the epithelium in regions such as 
the skin, eyes, throat etc.  Upon traumatic injury, the epithelium initiates an intra-
epithelial repair process which involves the expression of mitogenic and motogenic 
proteins such as keratinocyte growth factor (KGF)4.  Prior work from our labs has shown 
that exogenous addition of KGF in in vitro wound models can expedite the wound 
closure process5.  Biomaterial-based KGF delivery allows for localized and controlled 
delivery of KGF to the wound4, 6-9.  The goal of our present research program is to 
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develop and characterize a HEMA-based KGF delivery system that is to be used as an 
interface between the connective tissue and epithelium, while stimulating the wound 
healing process.  The wound healing process is initiated by the binding of KGF to the 
KGF-receptor, which is a cell surface signal transducing receptor of the tyrosine kinase 
family10. This binding event leads to cell division and migration of epithelial cells to the 
wound site, thereby stimulating the wound healing process. KGF binding to the KGF-
receptor is mediated by KGF binding to heparin prior to receptor binding, which 
eventually results in the formation of a KGF-heparin-KGF receptor complex.  Therefore, 
the heparin binding ability of KGF is an initial indicator of its biological activity, and 
KGF must retain its native conformation and orientation in order to carry out this role10. 
 Previous studies utilizing 2D correlation spectroscopy of a HEMA-based KGF 
delivery system developed in our labs have shown that while the HEMA system allows 
for efficient loading and extended release of KGF, 40% of the loaded KGF becomes 
trapped at the hydrogel surface and denatures.  The results of this study showed that the 
interaction between HEMA and KGF disrupts loop structures of the protein responsible 
for heparin binding interactions.  Therefore, we suspect that the interaction between 
HEMA and KGF mimics the KGF-heparin interaction due to the hydrophilic nature of 
HEMA11. 
 In order to evaluate modified, second generation systems for KGF delivery that 
move towards circumventing the issues of incomplete release and eventual denaturation, 
we have chosen to pull together knowledge from prior work on protein adsorption on 
biomaterial surfaces and prior work on hydrogel development.   
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Protein adsorption on biomaterial surfaces has been viewed as an issue to 
understand and prevent; certain materials of interest as biomedical implants have been 
shown to cause adsorption of common blood proteins12.  These blood proteins such as 
serum albumin, fibrinogen, fibronectin, and von Willebrand factor adsorb in orientations 
that allow for binding to cell surface receptors which leads to the activation of pathways 
involved in clotting and potential thrombus formation12-26.  While the activation of 
thrombus formation by blood proteins due to adsorption onto implant surfaces is not ideal 
and potentially catastrophic, we want to promote KGF orientations at our hydrogel 
surface that are able to bind heparin and the KGF cell surface receptor.  However, 
surfaces of interest as implants such as polystyrene, polycarbonate, titanium, poly-methyl 
methacryate etc. rarely possess characteristics of a drug delivery device such as the 
ability to load proteins into a material, and release and deliver proteins over time.  It is 
possible that a blend of a material promoting adsorption with HEMA may lead to a 
receptor-accessible orientation of KGF at the surface. 
Hydrogels are known to present viscoelastic features similar to those of biological 
tissues.  Pores within the hydrogel network have the capacity to incorporate components 
from different biological matrices, and release of these components can be adjusted by 
varying pore size created by the percent of crosslinker used.  Hydrogels also are reported 
to have good biocompatibility given that no pH changes occur during release due to 
degradation, and because organic solvents are not required for synthesis.  Release of 
protein has been reported to be due to the collapse of pores in HEMA hydrogels, and the 
controlled release of numerous proteins has been investigated3, 15, 27.  HEMA hydrogels 
also have bioadhesive properties, and are currently FDA approved wound adhesives28.  
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However, hydrogel based protein delivery systems have yet to be clinically translated due 
to the lack of studies on the biological activity of released proteins and proteins at the 
hydrogel surface throughout the release process.  Hydrophilicity of the hydrogel 
promotes diffusion of water and solutes into the porous network.  Carboxylic acid-
containing monomers such as methacrylic acid have been reported to increase 
hydrophilicity29-33.   A HEMA/MAA hydrogel may promote increased diffusion of KGF 
and potentially increase the concentration of KGF in and at the hydrogel surface.  
However, this may be negated by stronger interactions between KGF and the hydrogel, 
which could lead to poor release profiles and potential denaturation of KGF at the 
hydrogel surface. 
Our approach to the development and evaluation of second-generation KGF delivery 
systems is to synthesize hydrogel blends that incorporate (1) methyl methacrylate 
(MMA), which is known to promote protein adsorption, and (2) methacrylic acid (MAA), 
which promotes a higher hydrogel water content and increased protein diffusion34. For 
the reasons we have argued above, MMA and MAA containing HEMA hydrogels were 
also extensively studied in contact lens applications in studies on preventing protein 
adsorption27, 35-39.  However, to the best of our knowledge, the surface characterization of 
these blends using ToF-SIMS has not been reported.  We report the characterization of 
these hydrogels, FTIR-ATR spectroscopy for the analysis of KGF conformation, ToF-
SIMS in conjunction with principal component analysis (PCA) to compare KGF 
orientation across the surface of the HEMA/MAA, HEMA/MMA, and HEMA blends, as 
well as release profiles for these hydrogels. 
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II. EXPERIMENTAL 
2-hydroxyethyl methacrylate, (HEMA, contains ≤ 50 ppm monomethyl ether 
hydroquinone as inhibitor, SKU 477028), methacrylic acid (MAA, contains 250 ppm 
monomethyl ether hydroquinone as inhibitor, SKU 155721), methyl methacrylate (MMA, 
≤ 30 ppm monomethyl ether hydroquinone as inhibitor, SKU 55909), trimethylolpropane 
triacrylate (TMPTMA, contains 600 ppm monomethyl ether hydroquinone as inhibitor, 
SKU 246808), 2,2′-Azobis(2-methylpropionitrile) (AIBN, SKU 441090), benzoin methyl 
ether (BME, 96%, SKU B8703), chlorotrimethylsilane (SKU 386529), phosphate 
buffered saline (PBS, pH 7.4, liquid, sterile filtered and suitable for cell culture, SKU 
806552), and glycerol (SKY G9012) were purchased from Sigma Aldrich.  Human 
Recombinant Keratinocyte Growth Factor (KGF) was purchased from Prospec, and the 
Alexa FluorTM 488 Microscale Protein Labeling Kit was purchased from Invitrogen 
(catalog #A30006). 
A. Hydrogel blend preparation 
0.5% crosslinked HEMA hydrogels were prepared by using HEMA, 0.5 vol % 
TMPTMA, and 0.2% BME dissolved in glycerol.  The components were then mixed, 
degassed, and injected in between silanized glass slides that were separated by a 1.1 mm 
thick Teflon spacer, and allowed to polymerize under UV light for 30 minutes.  
HEMA/MMA and HEMA/MAA hydrogels were prepared using 5.89 mol % of MMA or 
5.89 mol % MAA, 0.5 vol % TMPTMA, 94.1 mol % HEMA, 0.128 mol % AIBN.  The 
components were then mixed and injected in between silanized glass slides that were 
separated by a 1.1 mm thick Teflon spacer, and were cured for 12 hours at 50oC and then 
for 24 hours at 70oC.  All hydrogels were removed from the glass slides and washed three 
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times at 70oC in triply distilled water.  Glass slides were silanized in a dessicator under 
vacuum using chlorotrimethylsilane.  Hydrogels were cut into 1x1 cm pieces and oven 
and vacuum dried prior to uptake, release, swelling, and ToF-SIMS experiments.   
B. FTIR-ATR measurements 
Spectra of unlabeled KGF at the surfaces of the HEMA, HEMA/MMA, and 
HEMA/MAA hydrogels were acquired using a Spectrum TwoTM FTIR Spectrometer 
equipped with a Universal ATR accessory containing a diamond/ZnSe crystal.  64 scans 
were acquired for each sample at 4 cm-1 resolution.  The Spectrum software was used to 
convert spectra from transmittance to absorbance, baseline correction, and ATR 
correction.  Hydrogels were prepared by incubation in 250 nM KGF solutions in PBS for 
2 hours, and spectra of hydrated samples were acquired.  KGF spectra were determined 
by background subtraction using hydrogels that had been incubated in PBS only. 
C. Deconvolution of FTIR-ATR data 
The amide I and amide I regions of the obtained spectra were Fourier self-
deconvoluted using Origin Pro 2017.  Parameters for deconvolution were 0.5 for gamma 
and 0.1 for smoothing.   
D.  ToF-SIMS 
1x1 cm hydrogels were incubated with 62.5 nM KGF in PBS for 2 hours.  In 
order to remove salts and loosely bound KGF, all hydrogels were rinsed in stirred triply 
distilled water for two times for 30 seconds each.  Hydrogels were then oven dried and 
vacuum dried.  Hydrogels without KGF were also oven dried and vacuum dried.  Positive 
secondary ion spectra were acquired on an ION-TOF V instrument (IONTOF, GmgH, 
Munster, Germany) using a Bi3
+ primary ion source kept under static conditions (primary 
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ion dose < 1012 ions/cm2).  Three positive spectra from two samples per hydrogel blend 
type were collected from 100 x 100 μm regions (128 x 128 pixels).  A pulsed flood gun 
was used for charge compensation.  The ion beam was moved to a new spot on the 
sample after acquiring each spectrum. Spectra were acquired using high current bunched 
mode over a range of 0-1000 m/z.  Mass resolution (m/∆m) was between 4000 and 7000.  
Hydrogel samples without KGF were calibrated using CH3
+, C2H3
+, and C3H5
+, and 
hydrogel samples with KGF were calibrated using CH3
+, C2H3
+, C3H5
+, and C5H10N
+.  
Mass calibration errors were kept below 20 ppm.   
E. Multivariate Analysis 
Peak lists were compiled for PCA analysis using the Ion-Tof SurfaceLab 
software.  PCA analysis of the hydrogel blends without KGF used a peak list consisting 
of all peaks in the 0-200 m/z range greater than 3 times the background.  PCA analysis of 
the hydrogel blends with KGF used a peak list of reported amino acid fragments in the 0-
200 m/z range.  Amino acid fragments that overlapped with fragments from HEMA, 
MMA, or MAA were eliminated from the peak list, and resulted in a final list of 11 
amino acids.  Peak lists were imported into the NESAC/BIO NBToolbox “spectragui” 
program written for MATLAB (Mathworks, Inc. Natick, MA)40.  Data sets were 
normalized using the sum of selected peaks, mean centered, and square root transformed 
prior to PCA analysis.   
F. Fluorescence monitoring of KGF uptake and release from 
hydrogel blends 
KGF was labeled with Alexa FluorTM 488 using the Microscale Protein Labeling 
Kit.  Fluorescence measurements were taken using a Qubit 3.0 Fluorometer.  Uptake and 
release into and from the blends was monitored by preparing cuvettes containing 1 mL of 
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labeled KGF solution in PBS.  1x1 cm oven-dried hydrogels were placed in the solution 
and kept in the dark, and the decrease in fluorescence of the labeled KGF was monitored 
over 24 hours.  Uptake fluorescence was corrected for water content taken up into the 
hydrogel over time (see swelling experiment).  Release fluorescence measurements were 
made by placing the protein loaded hydrogel in a cuvette containing 1 mL fresh PBS in a 
37oC water bath and monitoring the increase in fluorescence over 2 hours.  2 replicates 
were performed for each hydrogel type.  Release assays were limited to 2 hours given 
that previous (not reported here) experiments show that all possible release from HEMA 
based hydrogels occurs within this time frame. 
G. Swelling experiments 
1x1 cm oven and vacuum dried HEMA, HEMA/MMA, and HEMA/MAA 
hydrogels were used for swelling experiments.  Hydrogels were initially weighed, and 
then placed into cuvettes containing 1 mL PBS.  The increase in weight of the hydrogels 
was monitored at 5 mins, 15 mins, 30 mins, 1 hours, and 2 hours.  2 replicates were 
performed for each hydrogel type.  Percentage swelling was calculated using the equation 
(Mt – Mo)/Mo x 100%, where Mt is the mass of the swelling hydrogel at time t, and Mo is 
the initial mass of the dry hydrogel.   
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III. RESULTS 
A. Surface characterization of the hydrogel blends by ToF-
SIMS and PCA 
The surface percent of the 5.89 mol % MAA in HEMA and 5.89 mol % MMA in 
HEMA blends was calculated by using the (C4H9
+/(C4H9
+ + C2H5O
+)) and the (C2H3O2
+/( 
C2H3O2
+ + C2H5O
+)) peak area ratios respectively41, 42.  The surface percent of MAA in 
the HEMA/MAA blend is 5.39 ± 1.98 % and the surface percent of MMA in the 
HEMA/MMA blend is 2.84 ± 0.51 %.  The large standard deviation in the surface percent 
of MAA in the HEMA/MAA blend indicates the possibility of phase segregation at the 
surface of MAA regions at the surface, while this is not seen in the HEMA/MMA blend.  
The distribution of MAA and MMA surface percent across the samples and 
representative spectra of the three different blends are shown in figures S1-1 and S1-2 of 
the supplementary material. 
PCA on these blends utilizing a peak list of all the peak contributions from 
HEMA between 12-200 m/z was performed in order to determine whether the surfaces 
were distinguishable.  PC1 captured 61% of the variance in the data set, and the 
HEMA/MAA and HEMA/MMA surfaces were distinguishable at the 95% confidence 
level43, while the HEMA/MAA and HEMA surfaces were not distinguishable, and the 
HEMA/MMA and HEMA were distinguishable.  PC1 loadings showed that the 
HEMA/MMA blend was distinguished from the HEMA/MAA and HEMA blends by 
C2H6
+, C3H8O
+, C5H10
+, and C4H9O
+, while the HEMA/MAA and HEMA blends are 
distinguished from the MMA blend by C4H10
+ and C4H11
+. The PCA scores also show 
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that the HEMA/MMA samples appear relatively homogeneous while heterogeneity was 
seen in the HEMA/MAA and HEMA blends.  PC2 captures 19% of the variance and the 
three blends are not distinguishable at the 95% confidence interval as seen in figure S1-3 
of the supplementary material.  However, the HEMA/MAA blend exhibits both positive 
and negative scores while the HEMA/MMA and HEMA blends only exhibit positive 
scores.  The peak with the most prominent negative loading in PC2 was due to C2H5O
+.   
While the HEMA/MAA and HEMA blend surfaces are not distinguishable by 
PCA analysis, differences in protein orientation and conformation at the surfaces of these 
blends is still of interest.  Additional factors such as phase segregation and topography 
may contribute to differences in protein orientation and conformation at the surface, and 
are the subject of future investigations. 
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Figure 1. (a) PC1 confidence limits (95%) of the three hydrogel blend surfaces and (b) 
PC1 loadings 
 
 
 
 
 
 
Figure 2.  Structures of the hydrogel blends that were crosslinked for the formation of 
pores 
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B. KGF conformation: KGF at the surface of the HEMA/MAA 
blend appears to be denatured; FSD analysis 
Figure 3 shows the amide I and amide II regions of FTIR-ATR spectra 
corresponding to KGF conformation at the three different hydrogel surfaces.  The highest 
concentration of KGF is seen at the surface of the HEMA/MAA blend, potentially due to 
increased protein diffusion at the surface and into the porous network due to additional 
hydrogen bonding from the carboxylic acid in MAA.  The HEMA-only hydrogel shows 
the lowest KGF surface concentration.  The HEMA/MMA blend may present a higher 
KGF surface concentration than the HEMA blend due to increased adsorption on the 
surface. 
Fourier self-deconvolution of the amide I regions has been used to interpret 
conformational changes in KGF.  The amide I region is our region of focus due to its 
ability to reflect changes in protein secondary structure.  The relative intensities of the 
peaks at 1634 and 1643 cm-1 peaks corresponding to the extended strands and 
irregular/disordered region have been shown in our prior work on KGF conformation to 
be indicative regarding whether KGF is folded in its native conformation or its heat-
denatured conformation.  Our previous work has shown that equal intensities indicate a 
native conformation while unequal intensities where the intensity of the 1643 cm-1 peak 
is lower than the intensity of the 1634 cm-1 peak indicate a denatured conformation11.  A 
denatured conformation of KGF is seen at the surface of the HEMA/MAA blend while a 
native conformation is seen at the surface of the HEMA/MMA and HEMA blends.  Our 
previous work has also shown that extended interactions with the HEMA hydrogel result 
in eventual denaturation of KGF due interactions mimicking hydrogen-bond driven KGF-
heparin interactions11.  A denatured conformation after only a two-hour incubation at the 
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HEMA/MAA surface indicates that these interactions may be occurring at a much faster 
rate due to the presence of MAA-based hydrogen bonding.  Furthermore, a much lower 
relative intensity in comparison to the peaks at 1634 and 1643 cm-1 peaks is seen at 1651 
cm-1, which corresponds to the loops of KGF (Figure 6).  There are two loops in KGF; 
the receptor (heparin)-binding loop and the loop at the beginning of the protein that is 
right next to an additional heparin-binding site. Therefore, it is possible that the 
HEMA/MAA blend is disrupting the loops through KGF-heparin mimicking interactions, 
resulting in a denatured conformation. The HEMA/MMA blend alternatively appears to 
target hydrophobic regions of KGF.  For example, a peak at 1634 cm-1 corresponding to 
the extended strands region between 1622-1634 cm-1 disappears in the KGF spectrum, 
and the crystal structure of KGF shows that the extended strands create a tightly bound 
hydrophobic core (Figure 6).  Overall, KGF adopts a native conformation on the surfaces 
of the HEMA and HEMA/MMA blends after a two-hour incubation, while it appears to 
denature at the surface of the HEMA/MAA blend.   
 
 
 
 
 
 
 
Figure 3.  Original and Fourier self-deconvoluted spectra of KGF on the surfaces of the 
three hydrogel blends. 
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C. KGF orientation: ToF-SIMS and PCA show that KGF 
hydrophobic amino acids are exposed at the HEMA/MAA 
blend surface while hydrophilic amino acids are exposed at 
the HEMA/MMA blend 
Differences in KGF orientation at the surface of the hydrogel blends due to MMA 
and MAA addition were studied by PCA of the ToF-SIMS results.  Differences in 
orientation were best revealed when a peak list consisting of only amino acids were used.  
Positive ToF-SIMS spectra were used for PCA analysis due to a history of positive 
spectra being informative regarding protein orientation13, 14, 16, 18, 43.  Amino acid 
fragments that overlapped with peaks from HEMA, MMA, or MAA were omitted from 
the peak list, which resulted in a final peak list of 11 amino acids as shown in figure S2-2 
of the supplementary material.   
Figure 4 of PC1 scores shows that PC1 captures 54% of the variance in the data.  
KGF orientation at the HEMA/MMA and HEMA/MAA blend surface regions are 
distinguishable at the 95% confidence level43.  KGF orientation at the HEMA surface 
regions displays characteristics seen in both the HEMA/MMA and HEMA/MAA blends.   
Amino acids used in the peak list were characterized as polar/hydrophilic and 
aliphatic/hydrophobic in order to determine whether the PC1 loadings indicated a pattern 
for KGF orientation. Hydrophilic amino acids were found to have positive loadings while 
hydrophobic amino acids had negative loadings.  PC1 loadings shown in Figure 4 
indicate that the aliphatic amino acids alanine and isoleucine/leucine were detected in 
high intensities at the surface of the HEMA/MAA blend while polar amino acids serine, 
threonine, glutamine, arginine, and phenylalanine were detected in high intensities at the 
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surface of the HEMA/MMA blend.  These results suggest that aliphatic amino acids are 
oriented outwards while polar and mostly hydrophilic amino acids interact with the 
HEMA/MAA surface, and that polar/hydrophilic amino acids are oriented outwards 
while aliphatic amino acids interact with the HEMA/MMA surface.  Observations such 
as these on PMMA-containing surfaces have been previously reported44. 
PC2 captures 37% of the variance and creates a distinction between the 2 different 
HEMA/MMA samples that were studied (3 different regions studied on each sample, see 
figure S2-1 in the supplementary material).  PC2 scores indicate that there is significant 
heterogeneity in protein orientation among the HEMA/MMA samples.  This suggests the 
possibility of different amounts of phase segregation at the surface caused by the 
formulation method that may be causing minor differences in protein orientation among 
the HEMA/MMA samples. The HEMA/MAA and HEMA blends appear homogenous in 
PC2, and PC2 loadings indicate no clear pattern distinguishing orientation at the surface 
of the HEMA/MMA blend.   
Figure 6 is a structure of KGF with hydrophobic (pink, Ala, Gly, Val, Ile, Leu) 
and hydrophilic (blue, all remaining) amino acids labeled and shows that 
aliphatic/hydrophobic amino acids are mostly found to flank the beginning and end of the 
6 beta sheets near the solvent exposed reverse turns, while the polar/hydrophilic amino 
acids are found in the middle of the beta sheets.  Though only 11 (12 including Ile/Leu) 
amino acids are included in the PCA, we believe that our results are representative of the 
system because Figure 6 shows that hydrophobic and hydrophilic amino acids tend to 
localize separately in KGF.  Given this knowledge, we believe that inclusion of the 
remaining amino acids in the PCA would be beneficial but is not possible due to the 
 18 
fragmentation of the hydrogels, and we are comfortable forming the conclusions 
discussed below. 
Of particular importance are the positive loadings of serine, and threonine in PC1.  
Mutations in residues S122, and T126 to alanine correspond to the biological activity 
being reduced to 70%, and 60% when evaluated based on tritiated thymidine uptake in 
Balb/MK cells45.  These residues are in the receptor-binding loop (residues 122-132).  
Their higher normalized intensities at the HEMA/MMA surface seen in Figure 5 in 
comparison to the HEMA/MAA surface indicate an orientation more likely to bind the 
KGF receptor.   
The results suggest that the HEMA/MAA blend specifically targets 
aliphatic/hydrophobic amino acids of the beta sheets near solvent exposed regions and 
does not show accessibility of residues involved in receptor binding, while the 
HEMA/MMA blend specifically targets polar/hydrophilic amino acids found within the 
receptor binding loop and beta sheets.  Implications of these differing orientations on the 
receptor binding abilities of KGF and the biological activity of these hydrogels on wound 
closure are the subject of future experiments. 
 
 
 
 
 
Figure 4. (a) PC1 confidence limits of protein orientation on the hydrogel surfaces and 
(b) PC1 loadings 
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Figure 5.  Peak intensities of serine and threonine when normalized by the sum of 
selected peaks 
 
 
 
 
 
 
 
 
 
Figure 6.  Crystal structure of KGF (PDB ID: 1QQK46) with hydrophobic (pink) and 
hydrophilic amino acids labeled (blue).  Structure created in PyMol. 
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D. Effect of hydrogel composition on bulk properties 
Swelling, uptake, and release of Alexa FluorTM 488-labeled KGF (AF-KGF) from 
the hydrogel blends was evaluated in order to determine the effects of the changes in bulk 
and surface composition on water content and KGF delivery.  Surprisingly, and contrary 
to previously published literature34, changes in composition had no statistically 
significant effect on swelling over 2 hours (at the 0.05 level, F2,2 = 3.71, p > 0.05) with 
45, 50, and 52% swelling for the HEMA/MMA, HEMA/MAA, and HEMA blends 
respectively.  The percent of initially loaded AF-KGF taken up into the hydrogels after 
24 hours also was not statistically significant (at the 0.05 level, F2,2 = 2.40, p > 0.05) with 
7, 11, and 20% uptake for the HEMA/MMA, HEMA/MAA, and HEMA blends 
respectively.  Finally, the percent of loaded AF-KGF released after 2 hours was not 
statistically significant either (at the 0.05 level, F2,2 = 0.96, p > 0.05) with 62, 58, and 
44% of loaded AF-KGF released.  Therefore, the changes in bulk and surface 
composition of the hydrogels upon addition of MMA and MAA did not improve our 
previously reported concerns regarding incomplete release of KGF potentially due to 
trapping and denaturation of KGF at the hydrogel surface over time.  It is possible that 
the addition of larger percentages of MMA or MAA may address these concerns.  These 
results highlight the importance of evaluating both surface and bulk properties of newly 
modified materials when evaluating drug delivery systems.  Complete swelling, uptake, 
and release data can be found in figure S3-1 of the supplementary file.  The HEMA/MAA 
and HEMA/MMA blends differentially influence protein orientation and conformation 
without influencing swelling or protein uptake and release.  The three different KGF 
loaded hydrogel blends may therefore vary in biological activity, based on previous 
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reports on the influence of conformation and orientation on biological activity.  This will 
be the subject of future research efforts.   
 
IV. DISCUSSION 
The results of this study show that blends of HEMA hydrogels made to promote 
adsorption of protein at the surface or diffusion of protein into the surface affect protein 
orientation and conformation differentially.  We show that KGF detected at the surface of 
the HEMA/MMA hydrogel has a (1) greater percent of its amino acids oriented away 
from the surface than KGF at the surface of the HEMA/MAA hydrogel, with its 
hydrophobic amino acids interacting with the surface and it hydrophilic amino acids 
oriented outward, (2) KGF in an orientation likely to bind the KGF receptor, and that (3) 
KGF secondary structure remains in its native conformation.  Our observations regarding 
the orientation of hydrophobic and hydrophilic amino acids have been previously 
observed in AFM studies of BSA adsorbed at the surface of MMA/AA (acrylic acid) 
block copolymers44.  Hydrophilic groups of BSA were oriented away from the MMA 
surface and this was detected by differences in adhesive force between BSA 
hydrophilic/hydrophobic groups and the AFM tip.  The high intensities of PC loadings of 
amino acids responsible for biological activity have also been previously reported to be 
indicative of receptor-binding orientations16.  HEMA/MMA swelling and KGF release 
profiles in comparison to HEMA are unaffected by these surface-level changes. 
In contrast, we show that KGF detected at the surface of the HEMA/MAA hydrogel 
has (1) a smaller percent of its amino acids oriented away from the surface with its 
hydrophobic amino acids oriented away from the surface, (2) KGF in an orientation that 
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doesn’t expose amino acids involved in receptor binding, and (3) KGF in a conformation 
that resembles that of denatured KGF.  HEMA/MAA swelling and KGF release profiles 
in comparison to HEMA are also unaffected by these surface-level changes. 
PCA of the hydrogel blend surfaces (Figure 1) indicates that the HEMA/MMA 
and HEMA/MAA blends are distinguishable surfaces while the HEMA/MAA and 
HEMA surfaces are not.  PCA as well as characterization of surface content of MAA or 
MMA in the blends shows that the HEMA/MMA blend is relatively homogeneous while 
the HEMA/MAA blend is heterogeneous.  Surprisingly, KGF orientation at the 
HEMA/MMA blend is heterogeneous while KGF orientation HEMA/MAA blend is 
homogeneous (Figure 4).  This suggests that contributions from phase segregation and 
topography at these hydrogel blend surfaces and their effects on KGF orientation and 
localization are of interest in follow-up studies using SIMS imaging, XPS, and NEXAFS.   
PCA analysis of KGF orientation on the three surfaces shows that orientation on the 
HEMA/MMA blend is distinguishable from the orientation on the HEMA/MAA blend 
while the orientation on the HEMA blend cannot be distinguished from the other 
orientations on the other two blend surfaces, and has loadings in PC1 that overlap with 
loadings contributing to orientation on HEMA/MMA and HEMA/MAA.    Therefore, 
analysis of KGF orientation and characterization of the hydrogel blend surfaces tells us 
that differences in between the blends are specifically due to the presence of the additives 
MMA or MAA.    
The PCA results of KGF orientation suggest that the hydrophobic amino acids of 
KGF including alanine, isoleucine, leucine are oriented outwards facing away from the 
HEMA/MAA surface while the hydrophilic amino acids likely interact with the 
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hydrophilic HEMA/MAA surface (Figure 4). The crystal structure of KGF indicates that 
these hydrophobic amino acids are mostly found in regions flanking the beginning and 
ends of the 5 extended strands and 6th disordered extended strand.  These amino acids are 
therefore in close proximity to the solvent exposed reverse turns of KGF as seen in 
Figure 6.  Amino acids such as serine, and threonine are not seen in PC loadings 
corresponding to KGF orientation at the HEMA/MAA surface. The FTIR-ATR spectrum 
of KGF at the HEMA/MAA surface indicates disruption of the extended strands and 
disordered regions leading to the adaption of a conformation that resembles that of 
previously reported heat-denatured KGF.  It is likely that this observed conformation 
with changes in the extended strands and disordered regions is caused by the distortion of 
KGF due to the flanking hydrophobic regions of the extended strands being oriented 
away from the HEMA/MAA surface while the interior hydrophilic regions of the 
extended strands are interacting with the HEMA/MAA surface.   
The FTIR-ATR spectrum also shows disruption of the loop regions.  Past work on 
KGF conformational changes at the surface of the HEMA hydrogel over time has shown 
that the sequence of events leading eventual adoption of a conformation resembling that 
of heat-denatured KGF is initiated by an interaction between HEMA and the loops that 
potentially mimics the hydrogen bond-mediated interaction between KGF and its ligand 
heparin11.  Given that the PCA shows that KGF orientation at the HEMA surface and 
KGF orientation at the HEMA/MAA surface are not distinguishable at the 95% 
confidence level, it is possible that a similar conformational mechanism involving a loop-
surface interaction is leading to the denatured conformation of KGF at the HEMA/MAA 
surface.  While such a mechanism can only be proven by follow-up studies of 2D 
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correlation spectroscopy of KGF conformation at the HEMA/MAA surface, it is likely 
given (1) the structural similarity between MAA and HEMA with both containing 
hydrogen-bonding capability, and (2) PCA results of the blends in Figure 1 showing that 
the HEMA/MAA and HEMA blends are not distinguishable at the 95% confidence level 
in PC1 and PC2.     
PCA results of the amino acids at the HEMA/MMA surface shows that 
hydrophilic/polar amino acids serine, proline, threonine, glutamate, arginine, and 
phenylalanine are oriented outwards while it is likely that hydrophobic amino acids are 
interacting with the HEMA/MMA surface in hydrophobic-hydrophobic interactions.  
Serine, and threonine are found in the receptor binding loop, and display high normalized 
intensities at the HEMA/MMA in comparison to the other two surfaces. Interestingly, 
hydrophilic/polar amino acids are found both (1) buried within the extended strands away 
from the solvent exposed reverse turns and (2) also in the solvent exposed loops and 
disordered regions.  This suggests that both the hydrophobic nature of MMA and 
hydrophilic nature of HEMA may be contributing to interactions with different parts of 
KGF.  This is backed up by the fact that the orientation of KGF at the HEMA surface is 
not distinguishable from the orientation of KGF at the HEMA/MMA surface at the 95% 
confidence level, even though KGF orientation at the HEMA/MAA and HEMA/MMA 
surfaces is distinguishable.   
The FTIR-ATR spectrum of KGF at the HEMA/MMA surface indicates that the 
extended strands are disrupted, but not in a way that leads to disruption of the disordered 
regions or loops which can lead to denaturation seen at the HEMA/MAA surface.  
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Overall, in comparison to the orientation of KGF seen at the HEMA/MAA surface, more 
regions of KGF are accessible and oriented outwards as indicated by the PCA results.   
The purpose of this study has been to characterize how the addition of MAA or 
MMA to the HEMA blend affects KGF orientation differentially, while also 
characterizing whether KGF conformation remains intact or appears to denature.  Given 
that the results of our previous study showed that KGF denatured after extended time 
spent at the HEMA surface during the release process, we hypothesized that MAA 
addition may contribute to potential denaturation of KGF due to additional hydrogen-
bonding capability, while MMA may lead to a decreased interaction with KGF due to its 
hydrophobic nature.  Our results show that likely due to the additional hydrogen-bonding 
capability of the HEMA/MAA blend, the surface concentration of KGF is higher than 
HEMA/MMA and HEMA as shown by the area under the amide I region in the FTIR-
ATR spectrum (Figure 3), even though the overall percent of KGF taken up into the three 
hydrogels is indistinguishable by one-way ANOVA (figure S3-1 in the supplementary 
material). Although the HEMA/MMA blend has a lower KGF surface concentration, 
KGF maintains a close to native conformation, as shown in the FTIR-ATR spectrum, and 
allows for both internal amino acids of the extended strands and large portions of solvent 
exposed regions of KGF to be oriented away from the HEMA/MMA surface. In contrast, 
the HEMA/MAA blend leads to potential denaturation of KGF.   
It is important to note that surface concentration indicated by the FTIR-ATR 
spectra provides depth resolution of 1-2 µm into the surface, while the ToF-SIMS 
provides depth resolution of 1-2 nm of the surface.  Therefore, to summarize our 
interpretation of the results of this study, we believe that the HEMA/MAA blend 
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possesses characteristics that are beneficial in obtaining a high surface concentration of 
KGF.  The hydrogen-bonding capability at the surface likely leads to diffusion of KGF 
into the porous network and adsorption at the surface, which is observed in the high 
surface concentration of KGF seen at the HEMA/MAA surface.  However, this strong 
interaction likely leads to a less accessible orientation of KGF at the surface with receptor 
binding amino acids facing towards the hydrogel surface.  The ability of the 
HEMA/MAA blend to act as a drug delivery vehicle therefore depends on the strength of 
the HEMA/MAA interaction with KGF in comparison to the strength of the KGF-
receptor interaction in the presence of epithelial cells containing the KGF receptor.  We 
believe that the interaction between HEMA/MAA and KGF is potentially too strong, 
which leads to KGF denaturation and incomplete release.  However, this hypothesis can 
only be tested by follow up experiments that test the ability of KGF at the HEMA/MAA 
surface to bind its receptor in either in vitro heparin binding studies, or studies of the 
efficiency of wound closure in in vivo cellular assays that have been previously 
developed in our labs.   
Alternatively, we believe that the HEMA/MMA blend has a weaker interaction 
with KGF that is reflected by the lower surface concentration seen in the FTIR-ATR 
spectrum.  However, the overall concentration of KGF taken up into the HEMA/MMA 
hydrogel is indistinguishable from the KGF uptake in the other blends.  The 
HEMA/MMA blend doesn’t disrupt the conformation of KGF and denaturation is 
avoided potentially due to these weaker protein-material interactions, and the PCA results 
suggest that more regions of KGF are oriented away from the HEMA/MMA surface, and 
are more receptor-accessible.  This interaction is possibly beneficial in the development 
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of the ideal drug delivery device even though the HEMA/MMA bulk properties in the 
context of swelling, and uptake/release properties appear similar to the HEMA/MAA and 
HEMA blend.   
 
 
V. SUMMARY AND CONCLUSIONS 
We have characterized the abilities of HEMA/MMA and HEMA/MAA hydrogels 
to promote adsorption and diffusion at their surface related to KGF orientation and 
conformation by combining ToF-SIMS/PCA of the hydrogels, ToF-SIMS/PCA of KGF 
orientation, and FTIR-ATR spectra of KGF conformation.  While neither PMAA nor 
PMMA are ideal drug delivery vehicles, this approach has allowed for the 
characterization of differences in KGF orientation/conformation caused by new 
properties of the modified HEMA surfaces.  The HEMA/MMA formulation allows for a 
more receptor-accessible orientation of KGF that will potentially result in higher 
biological efficacy in expediting wound closure.  The HEMA/MAA formulation has an 
increased surface concentration of KGF, but the strength of the hydrogen bonding 
interactions between KGF and the hydrogel lead to a less receptor-accessible orientation 
and denaturation.  We believe that differences in receptor binding and efficacy in wound 
closure among the hydrogels will likely be due to differences in KGF orientation and 
conformation instead of differences in swelling and KGF release profiles.  We aim to 
focus future studies defining the role of phase segregation and porous topography on 
KGF localization and orientation/conformation, and we will evaluate the effects of KGF 
orientation, conformation, and localization on receptor binding and wound closure 
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through in vitro heparin binding assays and previously developed in vivo wound closure 
assays7. 
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S1:  Surface Characterization results of HEMA/MMA, HEMA, and HEMA/MAA hydrogel blends 
 
 
S1-1.  Surface vs. bulk % of MAA and MMA for HEMA/MAA and HEMA/MMA blend surface regions 
with error bars calculated by (C4H9+/(C4H9+ + C2H5O+)) and the (C2H3O2+/( C2H3O2++ C2H5O+)) peak area 
ratios from the ToF-SIMS spectra respectively 
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S1-2.  Representative ToF-SIMS spectra of (a) 5.89 mol % MAA in HEMA (b) 5.89 mol % MMA in 
HEMA (c) HEMA hydrogel surfaces 
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S1-3:  (a) PC2 vs. PC1 of the three hydrogel blends and (b) PC2 loadings for the three hydrogel blends 
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S2:  PCA of KGF orientation at the surface regions of the hydrogel blends 
 
 
 
 
 
 
 
 
 
S2-1.  (a) PC2 v. PC1 of KGF orientation at the hydrogel surfaces and (b) PC2 loadings 
 
Amino Acid m/z 
Alanine (C2H6N+) 44.05 
Serine (C2H6NO+) 60.0425 
Proline (C4H6N+) 70.0723 
Valine (C4H10N+) 72.065 
Threonine (C3H8NO+) 74.0606 
Glutamine (C4H8NO2+) 84.0411 
Lysine (C5H10N+) 84.0836 
Leucine/Isoleucine (C5H12N+) 86.098 
Arginine (C4H10N3+) 100.08 
Phenylalanine (C8H10N+) 120.0802 
Tryptophan (C11H8NO+) 170.057 
 
S2-2:  Amino acids included in peak list for positive spectra used in PCA 
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 S3:  Bulk characterization of swelling, uptake, and release of AF-KGF from the HEMA, 
HEMA/MMA, and HEMA/MAA hydrogels 
 
 
 
 
 
 
 
 
 
S3-1.  Values for percentage swelling after 2 hours, percent of 15 nM AF-KGF taken up into hydrogels 
after 24 hours, and percent of final loaded AF-KGF released after 2 hours.  Replicates for HEMA/MMA 
and HEMA/MAA release are not available. 
